MCC eCare Plan Implementation Guide
1.0.0 - STU1
MCC eCare Plan Implementation Guide
1.0.0 - STU1
This page is part of the MCC eCare Plan Implementation Guide (v1.0.0: STU 1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
Generated Narrative: Condition problem-list-2
clinicalStatus: Active
verificationStatus: Confirmed
category: Problem
code: Metabolic acidosis (disorder)
subject: Patricia Noelle
onset: 2022-05-01
recordedDate: 2022-05-08
asserter: Dr. John Carlson
evidence
detail:
- Observation Gas panel - Arterial blood
- Observation pH of Arterial blood
- Observation Bicarbonate [Moles/volume] in Arterial blood
- Observation Carbon dioxide [Partial pressure] in Arterial blood
- Observation Oxygen [Partial pressure] in Arterial blood
- Observation Lactate [Moles/volume] in Serum or Plasma
- Observation Ketones [Moles/volume] in Blood
- Observation Electrolytes 1998 panel - Serum or Plasma
- Observation Sodium [Moles/volume] in Serum or Plasma
- Observation Potassium [Moles/volume] in Serum or Plasma
- Observation Chloride [Moles/volume] in Serum or Plasma
- Observation Bicarbonate [Moles/volume] in Serum or Plasma
- Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma
- Observation Carbon dioxide, total [Moles/volume] in Serum or Plasma
- Observation Protein [Mass/volume] in Serum or Plasma
- Observation Albumin [Mass/volume] in Serum or Plasma
- Observation Glomerular filtration rate/1.73 sq M.predicted among females [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
IG © 2020+ HL7 International / Patient Care. Package hl7.fhir.us.mcc#1.0.0 based on FHIR 4.0.1. Generated 2024-08-13
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change